Furthermore, matrine significantly reduced the protein expression levels of p-AKT and p-mTOR and enhanced the LC3 II/GAPDH ratio in the tumors, consistent with the results obtained from the analysis of NB cells in vitro (P < 0.05) (Fig. 6D). The gene discussed is AKT1; the disease is neuroblastoma.